Latest

PT-141

PT-141 (Bremelanotide): The FDA-Approved Sexual Function Peptide — Science Deep Dive

PT-141 (Bremelanotide): Mechanism, Efficacy, and Clinical Considerations PT-141, marketed under the brand name Bremelanotide, represents a significant advancement in pharmacological treatment for hypoactive sexual desire disorder (HSDD) in women. In June 2019, the FDA approved Bremelanotide as the first melanocortin receptor agonist indicated for premenopausal women with generalized HSDD, making

By Medici

Tirzepatide

Tirzepatide: Mechanism, Clinical Trials, and How It Compares to Semaglutide

The Dual Mechanism: Understanding Tirzepatide's GIP/GLP-1 Action Tirzepatide represents a significant advancement in peptide pharmacology by targeting two distinct hormone receptors simultaneously. Unlike semaglutide, which functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. This dual mechanism distinguishes

By Medici

Is That Peptide Clinic Actually Legit? 10 Questions to Ask Before You Inject Anything

Peptide clinics are everywhere now. Medical spas, wellness centers, telehealth platforms, hormone optimization clinics — they're advertising peptide protocols for weight loss, anti-aging, sexual performance, athletic recovery, and nearly everything else. Some of these clinics are excellent: run by board-certified physicians, sourcing from accredited compounding pharmacies, following evidence-based protocols,

By Medici
Support ✨
📞 Call
Hi there! Want to chat via voice? Click the Call button! 😊
🤖
Listening...
Speak naturally with the agent
📞